+ All Categories

Home > Documents > Early Management of NSTE-ACS: From the ED to the Cath Lab

Early Management of NSTE-ACS: From the ED to the Cath Lab

Date post:	31-Dec-2015
Category:	Documents
Upload:	stephanie-hess
View:	18 times
Download:	0 times

Download Report this document

Share this document with a friend

Description:

Early Management of NSTE-ACS: From the ED to the Cath Lab. Main Limitations of UFH. Fondaparinux*. Bivalirudin. Otamixaban. Early Management of NSTE-ACS: From the ED to the Cath Lab. Evaluation of Chest Pain. ACCF/AHA Recommendations for Initial Management of UA/NSTEMI. - PowerPoint PPT Presentation

Embed Size (px):

21

Transcript

Page 1: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 2: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 3: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 4: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 5: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 6: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 7: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 8: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 9: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 10: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 11: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 12: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 13: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 14: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 15: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 16: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 17: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 18: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 19: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 20: Early Management of NSTE-ACS: From the ED to the Cath Lab

Page 21: Early Management of NSTE-ACS: From the ED to the Cath Lab

Recommended

Pretreatement with oral P2Y12 inhibitors in NSTEMI and ... · Montalescot G, et al. N Engl J Med. 2013;369:999-1010 ACCOAST: 4033 patients with NSTE-ACS coronary angiography within

Stable CAD, NSTE-ACS, and STEMI: Three Challenging ...

What oral antiplatelet therapy would you choose? a) ASA ... SGG.pdf · 2651 5078 2591 Subgroup analysis of the PLATO trial in patients with NSTE ACS, including NSTEMI and unstable

Guidelines on NSTE-ACS (version 2015) - Task Force · Guidelines on NSTE-ACS (version 2015) - Task Force Expert Type of Relationship with Industry For ESC Guidelines: The report below

Operative Myokardrevaskularisation im akuten ... · 2014 ESC/EACTS Guidelines on myocardial revascularization Eur Heart J. 2014 5 NSTE-ACS: “Patients at very high risk (as defined

Dual Antiplatelet Therapy: Time for a Paradigm Shift? · 5 years after PLATO: ESC guidelines 2014 myocardial revascularization NSTE-ACS undergoing PCI STEMI undergoing PCI Windecker

Guidelines nste-acs-ft

2015 ESC Guidelines for the Management of NSTE-ACS

Gencer (Switzerland), Gerd Hasenfuss (Germany), Keld ... · –To focus on NSTE-ACS only –To implement novel treatments and strategies –To be exhaustive, consistent and pragmatic

Anticoagulation 2013 for NSTEMI and STEMI · zBivalirudin for STEMI, Fondaparinux for NSTE ACS, Coronary stents for ACS ... ≥12 h Sx non ST ↑ACS, mod–high risk ...

Final Copy NSTE-ACS for Presentation

2007 ESC NSTE-ACS GUIDELINES

EKG in STEMI · isk stratification iate management Manawment Prior to ... Differential diagnosis of NSTE-ACS includes (41): • Nonischemic cardiovascular causes of chest pain

2014 AHA/ACC Guideline for the Management of Patients …circ.ahajournals.org/content/circulationaha/early/2014/09/22/CIR... · Amsterdam EA, et al. 2014 AHA/ACC NSTE-ACS Executive

Guidelines nste-acs-slides

Heparin versus bivalirudin in patients with non ST ... · Bivalirudin vs Heparin in NSTE-ACS randomised trials •BAT trial (Bittl et al NEJM 1995;333:764-9) –4098 patients randomised

2014 NSTE-ACS Guidelines Overviewcm/@mwa/documents/downloadable/ucm_489665… · At the end of this presentation the learner will be able to: •Locate resources on ACS, Troponin,

CRUSADE: Contemporary Evaluation and Management of · PDF fileCRUSADE: Contemporary Evaluation and Management of 200,000 High-Risk NSTE-ACS Patients Page 2 AUGUST 2007 volUme 4 EmErgEncy